Menovazan ointment tube 40 g

Instructions for Menovazan ointment tube 40 g

Composition

active ingredients: 1 g of ointment contains racemic menthol 25 mg, novocaine (procaine hydrochloride) 10 mg, anestezin (benzocaine) 10 mg;

excipients: mineral oil, white soft paraffin, emulsifier T-2, purified water.

Dosage form

Ointment.

Main physicochemical properties: white ointment with a menthol odor.

Pharmacotherapeutic group

Antipruritic agents. ATX code D04A X.

Pharmacological properties

Pharmacodynamics

Menovazan is a combined drug and its properties are due to the action of the active components. In particular, due to the selective action of menthol on cold receptors, the ointment causes a feeling of cold, and the irritating effect can be replaced by slight anesthesia. Reflexively, menthol changes the tone of the vessels. This applies to both superficial vessels and vessels located deeper. Novocaine has a sufficiently pronounced anesthetic activity. It does not change the tone of the vessels. Anesthesin causes superficial anesthesia. The combination of these components in one drug provides the ability to cause a reverse violation of the excitability and conductivity of nerve receptors and conductors upon direct contact with them, to exhibit an irritating and distracting effect, to suppress the excitation of nerve fiber membranes, to reduce the amplitude of the action potential, to increase the threshold of depolarization of the nerve fiber membrane, to slow down the rate of development of the ascending phase of the action potential, to reduce the degree of excitation in nerve elements.

Pharmacokinetics

Not determined.

Indication

Neuralgia, myalgia, arthralgia; dermatoses accompanied by itching.

Contraindication

Hypersensitivity to the components of the drug.

Special safety measures.

Do not apply to skin with allergic reactions, facial skin, or damaged skin.

Interaction with other medicinal products and other types of interactions

It is not recommended to use it simultaneously with other local anesthetics (enhance the effects of drugs with local anesthetic action). The components of the drug (novocaine, anestezin) weaken the antibacterial effect of sulfonamide drugs.

If you are taking any other medications at the same time, you should inform your doctor.

Use during pregnancy or breastfeeding

There is no experience with the use of the drug during pregnancy or breastfeeding.

Ability to influence reaction speed when driving vehicles or other mechanisms

You should refrain from driving or operating other machinery as dizziness may occur.

Method of administration and doses

Apply externally 2-3 times a day for rubbing painful or affected skin areas. The course of treatment depends on the form and course of the disease, as well as on the nature of concomitant therapy. The maximum daily dose is 9 g.

Children

Do not use in children under 12 years of age.

Overdose

With prolonged use, dizziness, general weakness, decreased blood pressure, and allergic reactions are possible.

If such symptoms appear, the drug should be discontinued, the remains should be washed off the skin surface with water and consult a doctor. Treatment is symptomatic.

Adverse reactions

Allergic reactions (including hyperemia, skin irritation, itching, rash, edema, urticaria), contact dermatitis are possible.

Expiration date

3 years. Do not use the drug after the expiration date indicated on the package.

Storage conditions

Store at a temperature not exceeding 25 ºС in a place inaccessible to children.

Packaging

40 g in a tube in a pack.

Vacation category

Without a prescription.

Producer

LLC "SKP "Pharmaceutical Factory".

Location of the manufacturer and its business address

Ukraine, 12430, Zhytomyr region, Zhytomyr district, Stanyshivka village, Koroleva st., bldg. 4.